QC
DGX icon

Quent Capital’s Quest Diagnostics DGX Stock Holding History

Quent Capital’s Portfolio DGX Stock Details DGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$30.1K Buy
142
+68
+92% +$13.3K ﹤0.01% 949
2026
Q1 		$14.5K Sell
74
-44
-37% -$8.55K ﹤0.01% 1079
2025
Q4 		$20.5K Hold
118
– – ﹤0.01% 985
2025
Q3 		$22.5K Buy
+118
New +$20.9K ﹤0.01% 825
2025
Q2 		– Sell
-3
Closed -$508 – 534
2025
Q1 		$508 Hold
3
– – ﹤0.01% 1253
2024
Q4 		$453 Buy
+3
New +$467 ﹤0.01% 1277
2023
Q1 		– Sell
-10
Closed -$1.58K – 1331
2022
Q4 		$1.58K Sell
10
-12
-55% -$1.72K ﹤0.01% 1178
2022
Q3 		$3K Buy
22
+12
+120% +$1.58K ﹤0.01% 1036
2022
Q2 		$1K Buy
+10
New +$1.36K ﹤0.01% 1094

Other funds holding DGX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
EIG
EdgePoint Investment Group Toronto, Ontario, Canada $13.2B AUM 32.43% 1-Year Est. Return

Quent Capital's DGX Position: Q2 2026 in Review

Quent Capital increased its Quest Diagnostics (DGX) stake by 92% in Q2 2026, buying an estimated $13.3K and bringing the position to 142 shares worth $30.1K. The position accounts for ﹤0.01% of the portfolio, ranked #949.

Quent Capital first reported a position in DGX in Q2 2022 and has held it in 9 quarters since. 1,109 funds tracked by Wall St. Rank hold DGX as of Q2 2026.

  • Quent Capital held 142 shares of Quest Diagnostics worth $30.1K as of Q2 2026.
  • Quent Capital bought 68 Quest Diagnostics shares in Q2 2026, an estimated $13.3K.
  • Quest Diagnostics made up ﹤0.01% of Quent Capital's portfolio in Q2 2026, its #949 holding.
  • Quent Capital first reported a position in Quest Diagnostics in Q2 2022 and has held it in 9 quarters since.
  • 1,109 funds tracked by Wall St. Rank held Quest Diagnostics as of Q2 2026.

Based on Quent Capital's 13F filing for Q2 2026, filed 7 Aug 2026.